How Pharmaceutical E-commerce Can Become an Industry Rising Star in Five Steps

The development of pharmaceutical e-commerce in China is heavily constrained by key industry factors, with profound influences from pharmaceutical policies, regulations on online drug sales, and guidelines for diagnostic services. In the era of mobile internet, pharmaceutical consumption places greater emphasis on online-to-offline (O2O) collaborative operations, necessitating closer attention to these influencing factors. This requires us to enhance efficient pharmaceutical services through coordinated measures such as syndrome-specific diagnosis and treatment, consolidated medication guidance, and interconnected pharmaceutical services, thereby promoting efficient integration, connectivity, and interaction between online and offline channels. By creating an “efficient pharmaceutical e-commerce service ecosystem,” we can emerge as a new leader in the pharmaceutical industry.


I. Syndrome-Differentiated Diagnosis and Treatment with Targeted Medication
Each patient has their own symptom category, and each patient's symptoms are different. Even within the same disease type, there are different characteristics of the condition. For pharmaceutical e-commerce, it is not only necessary to diagnose the condition based on the patient's disease characteristics but also to provide different treatment and medication recommendations for different conditions. This is also the most critical step for pharmaceutical e-commerce.

1. Network-based Symptomatic Treatment and Drug Administration
For over-the-counter (OTC) medications, patients often self-assess their conditions based on symptoms and physical signs, selecting products according to physicians’ recommendations. In contrast, regarding prescription drugs, Wang Pengfei from Shanghai Taohui Consulting believes that, due to their involvement with complex or refractory diseases and more sophisticated treatment modalities, pharmaceutical e-commerce platforms must either collaborate with hospital physicians or independently establish an “online diagnosis and treatment system,” aiming to provide patients with symptom-specific diagnoses and corresponding medication guidance.

2. Design of Closed-Loop Diagnosis, Treatment, and Medication Administration Services
Pharmaceutical e-commerce differs from other e-commerce models in that it requires coordinated online and offline services. In addition to providing online syndrome-based diagnosis, digital communication, and medication guidance, it must also guide patients through actual condition verification and medication review at offline terminals. Furthermore, it facilitates the synchronization of patient data, symptoms, and treatment regimens between online and offline channels. Only through continuous online-offline operations and integrated verification mechanisms can pharmaceutical e-commerce platforms enhance patients’ sense of medication safety and strengthen their trust in the platform.

Typical practices of “Syndrome-Differentiated Diagnosis and Treatment with Targeted Medication” include: 1) Integrating essential “online symptom diagnosis systems” to conduct “syndrome differentiation and treatment” for patients through online preliminary consultations or remote diagnostics, thereby enhancing the scientific rigor and specificity of medication; 2) Strictly implementing standardized designs for “medication service processes,” ensuring that all aspects—from the procedural setup of online consultations and assignment of dedicated physicians to offline symptom re-evaluation and medication review—are governed by standardized protocols, thus guaranteeing the scientific appropriateness of patient medication.

II. Consolidated Medication Recommendations
Patients present with a wide variety of conditions and highly variable symptoms. For patients, timely and scientifically guided medication adherence is the most effective way to alleviate suffering, representing the core value proposition of pharmaceutical e-commerce platforms. In facing patients with diverse constitutions, varying clinical conditions, and multiple contraindications, pharmaceutical e-commerce platforms need to provide more integrated medication recommendations and higher-quality pharmaceutical care services, thereby enhancing patients’ overall experience in diagnosis, treatment, and medication management.

1. Provide integrated treatment plans
Each patient has multiple underlying causes for their illness and a unique physiological constitution. Therefore, medication regimens in pharmaceutical e-commerce must maintain relative flexibility. While reinforcing "disease-cohort-based treatment," it is essential to tailor protocols for special populations and individuals with distinct constitutions, adopting a case-by-case approach and providing integrated treatment plans based on individual diagnoses.

2. Integrate Professional Medical and Pharmaceutical Resources
Online pharmaceutical e-commerce is not merely about selling medications; prior to dispensing drugs, it must quantify the patient’s condition based on individual constitutions, symptoms, and other factors. This cannot be achieved through pharmaceutical resources alone. Therefore, online pharmaceutical platforms need to integrate broader medical resources to better serve patients. This includes collaborating with local specialized hospitals, departments, and physicians, as well as integrating online consultation platforms, with the aim of providing patients with one-stop, integrated services encompassing diagnosis, treatment, and medication management.

3. Promotion of “Pan-Family Medical Services”
From the perspective of patient conditions, medical diagnosis and treatment are often provided on an individual basis. However, family health management is equally important, particularly for diseases that are highly contagious or prone to infection, where greater attention must be paid to the health of patients’ family members. Additionally, there is another scenario: for certain chronic diseases with relatively simple treatments and stable clinical protocols, patients can complete their therapy at home. Wang Pengfei from Shanghai Taohui Consulting believes that while pharmaceutical e-commerce platforms provide services to individual patients, they can also expand into the family health management market, including areas such as household medication management, primarily targeting patient populations with infants or elderly family members.

“Integrated Medication Recommendations” aim to enhance the value delivered to individual patients by strengthening integrated medication regimens and highlighting integrated medication services. Typical practices include: 1) Promoting the implementation of “single-condition medications,” “combination therapies,” and “cycle-based medications”; providing optimized medication recommendations for specific conditions; offering diverse solutions for the same condition; delivering more targeted combination advice for over-the-counter (OTC) drugs; and providing comprehensive medication guidelines for chronic diseases; 2) Evolving from an “individual patient” focus to a “household user” approach, extending medication guidance from individual patients to entire families, and advancing services such as treatment course design and medication reminders to offer patients more comprehensive and integrated care.

III. Interconnected Pharmaceutical Services
We are already in a great era of mobile internet-driven consumption. Mobile internet-enabled pharmaceutical consumption is not only an inevitable industry trend but also the key to future growth. To advance the pharmaceutical e-commerce sector, efforts must be focused on leveraging the mobile internet context for pharmaceutical consumption, enhancing interconnectivity in medication purchasing, and optimizing online-to-offline (O2O) integrated pharmaceutical services.

1. "New Location-Based Services" in Mobile Internet
Patients’ medication services are highly diverse and exhibit strong location-based service characteristics. Pharmaceutical e-commerce platforms need to select nearby medical service points and prescription pickup locations based on the “user’s current location.” These purchasing characteristics have become even more pronounced in the era of mobile internet consumption. As pharmaceutical e-commerce advances its “new mobile internet location-based” services, it must further emphasize the value of location by integrating high-quality offline service terminals, thereby delivering superior service value in addition to product sales.

2. Integration of Online Guidance and Offline Services
Pharmaceutical e-commerce differs from traditional brick-and-mortar pharmacies in that patients’ initial interaction is not with the medication itself, but rather through digital channels—such as remote diagnostic consultations or online customer service on pharmaceutical platforms. These interactions serve as the patient’s “first touchpoint” and constitute their primary brand experience. By conducting preliminary online assessments, including initial symptom evaluation, tentative diagnosis, and medication recommendations, followed by offline services such as verification and guided medication administration, this integrated approach significantly enhances the patient’s O2O (Online-to-Offline) healthcare experience.

“Interconnected Pharmaceutical Services” aims to integrate online processes such as symptom assessment, treatment plan aggregation, and medication guidance, while strengthening offline services including verification and on-site guidance. By achieving interconnection, interoperability, and interaction between online and offline channels, this model seeks to drive leapfrog development in pharmaceutical e-commerce. 1) Enhance the online consultation experience, ensuring that every patient receives high-quality initial symptom assessment, medication advice, and communication support, along with effective self-diagnosis guidance and medication services. Meanwhile, offline verification and on-site guidance help reinforce patients’ trust in and reliance on e-commerce platforms; 2) Strengthen functional integration at offline terminals, transforming traditional pharmaceutical outlets from mere product vendors into comprehensive, integrated service hubs. These outlets will assume responsibilities such as providing medical services, medication guidance, patient communication, and brand promotion, thereby realizing a three-dimensional, interconnected, and highly interactive healthcare and pharmaceutical service ecosystem across online and offline channels.

IV. Construction of Multi-layered Doctor-Patient Communities
In pharmaceutical e-commerce, advancing the O2O (Online-to-Offline) model necessitates the development of community-based platforms. Given that the pharmaceutical industry directly impacts personal safety and medication health, it requires support from specialized medical resources. Therefore, it is essential to establish a professional community framework that facilitates better communication and interaction between healthcare providers and patients.

1. Building Multi-Layered Healthcare and Pharmaceutical Ecosystems
Looking at the advancement of pharmaceutical e-commerce, whether it involves online specialized remote symptom diagnosis and patient medication guidance, or offline medication review and home medication follow-up, all require professional medical knowledge and refined pharmaceutical services. This necessitates the development of a professional medical and pharmaceutical ecosystem, including the recruitment of more specialized physicians, additional terminal pharmacists for patient-facing services, and more specialized online medical and pharmaceutical customer service representatives. Building such high-quality medical and pharmaceutical ecosystems is a critical step in the successful promotion of pharmaceutical e-commerce.

2. Strengthen Communication and Interaction within Doctor-Patient Communities
While diseases are ruthless, human compassion endures. Physicians’ professionalism must be communicated more effectively to patients, and patients’ self-reported symptoms need to be conveyed to physicians more accurately and promptly. Wang Pengfei of Shanghai Taohui Consulting believes that effective doctor–patient interaction is a critical link in the successful advancement of medical and pharmaceutical affairs. Enhancing physicians’ sense of recognition and professional confidence in mobile health, improving their specialized medical and pharmaceutical capabilities, and fostering greater interaction and communication between doctors and patients are also key measures to alleviate doctor–patient tensions and strengthen community stickiness in pharmaceutical e-commerce.

3. Embedding the Brand Spirit of Pharmaceutical E-commerce
In the era of mobile internet, community building is a widely discussed topic. Pharmaceutical communities, in particular, need to place greater emphasis on their brand value. While enhancing the visibility of their independent brand value, they must strengthen their unique brand spirit, deeply integrate this spirit into community development, fully articulate professional medical concepts, demonstrate high-quality professional medical services, and convey a deep sense of care and humanitarian professionalism.

Only when mobile internet communities establish a brand can they foster strong brand loyalty among users; with such high brand loyalty, pharmaceutical e-commerce platforms can achieve rapid growth and deliver higher-quality medical and pharmaceutical service experiences to users.

“Construction of Multi-Layered Doctor-Patient Communities” aims to provide a core community interaction platform for the operation of pharmaceutical e-commerce, offering a space for mutual exchange among various mainstream circles and online communities, thereby enhancing medical and pharmaceutical services for patients and creating a positive community interaction experience. 1) Build brand communities rather than merely forming groups. Given the frequent occurrence of doctor-patient disputes and conflicts, pharmaceutical e-commerce platforms need to highlight the power of their “e-commerce platform brand” to better address these issues. By promoting the brand value of pharmaceutical e-commerce platforms, communication with patients can be improved, and patient trust in the brand will naturally increase. 2) Facilitate effective connections across different circles. Offline events such as “Brand Gathering Days” can be organized to bring together VIPs and key opinion leaders from various medical and pharmaceutical circles to discuss professional medical issues and lifestyle health topics. Additionally, “Brand Networking Associations” can be established to gather high-frequency purchasing patients, highly influential professional doctors, and prominent pharmaceutical brands, thereby enhancing mutual understanding among different circles and promoting efficient communication.

V. High-Engagement Health Management
For common ailments, a small pill often suffices to resolve the issue. However, for chronic diseases and major health conditions, patients require not only pharmaceutical products but also continuous health management. This encompasses a range of services, from guiding individual pill intake to establishing periodic medication schedules and providing timely reminders for dose administration. Such comprehensive support is a crucial element in enhancing brand stickiness for e-pharmacy platforms.

1. Continuous Medication Tracking and Reminders
According to a special survey conducted on domestic mobile pharmaceutical apps, Chinese patients are most concerned about features such as “medication timing reminders” and “medication guidance.” They place greater emphasis on the continuity of the medication experience, the ongoing use of medications, and sustained physiological guidance during treatment.
Wang Pengfei of Shanghai Taohui Consulting believes that, correspondingly, pharmaceutical e-commerce platforms should also focus on providing genuine medication tracking services for patients. They should evolve from merely selling drugs to offering “continuous medication services,” progressing from timed medication reminders to regular, cyclical medication guidance, and advancing from simple medication verification to integrated medication management. By truly addressing issues from the patient’s perspective, these platforms can enhance the “thoughtful” medication experience for patients.

2. Post-Rehabilitation Nursing Guidance
For certain chronic diseases, treatment courses are prolonged and regimens remain relatively stable. In addition to prioritizing drug safety and high quality, patients place greater emphasis on affordable pricing and post-treatment rehabilitation guidance. Since drug prices exhibit relative rigidity, leaving limited room for price manipulation by pharmaceutical e-commerce platforms, promoting ancillary services such as post-acute rehabilitation nursing and medication guidance can better advance “chronic disease health management” and enhance patients’ medication experience.

“High-Engagement Health Management” is a key component in delivering refined, in-depth, and robust services centered on patient medication adherence, as well as a core driver for boosting the overall sales revenue and gross profit margin of pharmaceutical e-commerce platforms. 1) Refine chronic disease health management by truly addressing the pathogenesis, diagnostic methods, treatment regimens, and precautions associated with patients’ chronic conditions, while quantifying daily behaviors such as physical activity, diet, and home care based on individual patient characteristics; 2) Deepen and strengthen related services, recognizing that medication intake is only one aspect of patient recovery, whereas device-assisted therapy and self-directed exercise are essential components of rehabilitation and align with patients’ integrated care intentions. By integrating medication services, training guidance, dietary recommendations, and exercise advice around patients’ “health management needs,” such an approach is expected to be highly welcomed by patients.

China’s pharmaceutical O2O sector is in the ascendant and is poised for rapid growth alongside the swift development of China’s internet healthcare industry. Seizing this opportunity, pharmaceutical companies that excel in syndrome-based diagnosis and treatment with targeted medication delivery, integrated medication recommendations, interconnected pharmaceutical services, multi-tiered doctor-patient community building, and high-engagement health management will inevitably emerge as rising stars in the industry and secure a competitive advantage in an intensely competitive market.

To browse more insightful articles by Wang Pengfei, please clickWang Pengfei's Column Article Directory
This article is published on VCBeat with authorization from Wang Pengfei. Please obtain the author’s permission if you wish to reprint it.
Personal WeChat ID:wind53880Personal Email:wind53880@163.com